Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ChemoMetec AS's dividends per share for the
six
months ended in Dec. 2025 was kr7.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was kr7.00. Its Dividend Payout Ratio for the
six
months ended in Dec. 2025 was 1.30. As of today, ChemoMetec AS's Dividend Yield % is 1.70%.
Good Sign:
ChemoMetec AS stock Dividend Yield % is close to 5-year high.
During the past 12 months, ChemoMetec AS's average Dividends Per Share Growth Rate was 75.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of ChemoMetec AS was 58.70% per year. The lowest was 58.70% per year. And the median was 58.70% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
ChemoMetec AS (OCSE:CHEMM) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
ChemoMetec AS's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of ChemoMetec AS was 2.15. The lowest was 0.29. And the median was 0.57.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
ChemoMetec AS Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
DKK 7.000000
2025-10-10
2025-10-13
2025-10-14
Cash Dividend
annually
DKK:DKK 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
ChemoMetec AS's Dividend Yield (%) for Today is calculated as
Current Share Price is kr410.60.
ChemoMetec AS's Dividends per Share for the trailing twelve months (TTM) ended in Today is kr7.
During the past 13 years, the highest Dividend Yield of ChemoMetec AS was 2.22%. The lowest was 0.14%. And the median was 1.07%.
Good Sign:
ChemoMetec AS stock Dividend Yield % is close to 5-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS Dividends per Share Related Terms
ChemoMetec AS Dividends per Share Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:CHEMM vs ABT, SYK, MDT: Dividends per Share Comparison
For the Medical Devices subindustry, ChemoMetec AS's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's Dividend Yield % falls into.
ChemoMetec AS (OCSE:CHEMM) has a Dividends per Share of kr7.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on ChemoMetec AS and its competitors.
Is ChemoMetec AS's Dividends per Share too high?
ChemoMetec AS's current Dividends per Share is kr7.00. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Dividends per Share compare to ABT and SYK?
ChemoMetec AS's Dividends per Share of kr7.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Medical Devices & Instruments company?
A good Dividends per Share depends on the Medical Devices & Instruments industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on ChemoMetec AS and its competitors. ChemoMetec AS's current Dividends per Share is kr7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr551.60, compared to a current price of kr410.60 — trading 25.6% below its estimated fair value. The current Dividends per Share is kr7.00. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current Dividends per Share is kr7.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of kr410.60 is trading 25.6% below its estimated GF Value™ of kr551.60.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for OCSE:CHEMM:
Dividends per Share: kr7.00
GF Value™: kr551.60 vs. price of kr410.60 (25.6% below fair value)
No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for OCSE:CHEMM
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:CHEMM has been successfully added to your 
